Jefferies Reiterates Buy on Deckers Outdoor (DECK) Following 4Q

Go back to Jefferies Reiterates Buy on Deckers Outdoor (DECK) Following 4Q

Brean Capital Remains Bullish on Deckers Outdoor (DECK) Following Strong 4Q Results

May 27, 2016 9:52 AM EDT

Brean Capital maintained a Buy rating on Deckers Outdoor (NYSE: DECK), and cut the price target to $58.00 (from $67.00), following the company's 4Q earnings report. DECK delivered an EPS of $0.11, above consensus expectations for $0.06. Revenue growth of 11% y/y came in well above consensus estimates for +6%.... More

Piper Jaffray Raises Price Target on Deckers Outdoor (DECK) Following 4Q

May 27, 2016 8:01 AM EDT

Piper Jaffray reiterated a Neutral rating on Deckers Outdoor (NYSE: DECK), and raised the price target to $48.00 (from $47.00), following the company's 4Q earnings report. DECK reported sales of $379M, coming in ahead of Piper Jaffray's $362M estimate. Guidance for both Q1 and FY17 was below expectations.

Analyst Erinn Murphy... More

Citi Downgrades Deckers Outdoor (DECK) to Neutral

May 27, 2016 6:33 AM EDT

Citi downgraded Deckers Outdoor (NYSE: DECK) from Buy to Neutral.

For an analyst ratings summary and ratings history on Deckers Outdoor click here. For more ratings news on Deckers Outdoor click here.

Shares of Deckers Outdoor closed at $49.25 yesterday.

... More

After-Hours Stock Movers 05/26: (VNDA) (VVEV) (RLYP) Higher; (PANW) (GME) (SPLK) Lower (more...)

May 26, 2016 5:12 PM EDT

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) 9.9% HIGHER; announced that the U.S. Food and Drug Administration (FDA) has approved Vanda's supplemental New Drug Application (sNDA) for Fanapt®, modifying and expanding the prescribing information (PI) to describe the effectiveness of Fanapt® as a maintenance treatment for schizophrenia in adults. FDA approval was based on the results of the REPRIEVE (Relapse prevention study in patients with schizophrenia) placebo-controlled clinical study which evaluated the long-term maintenance of efficacy and safety of Fanapt®. The study data submitted in the sNDA came from the... More

Deckers Outdoor (DECK) Tops Q4 EPS by 5c, Guides Lower; CEO Out

May 26, 2016 4:13 PM EDT

Deckers Outdoor (NYSE: DECK) reported Q4 EPS of $0.11, $0.05 better than the analyst estimate of $0.06. Revenue for the quarter came in at $378.6 million versus the consensus estimate of $362.08 million.

Dave Powers will succeed Angel Martinez as Chief Executive Officer of Deckers Brands following Mr. Martinezs retirement, effective May 31, 2016. Mr. Martinez will continue to serve as Chairman of the Companys board of directors.

Our stronger than expected fourth quarter Non-GAAP operating results are very encouraging given the current market environment, commented Angel Martinez, Chief Executive Officer and Chair of the Board... More

Deckers Outdoor (DECK) Names Successor to CEO Martinez

May 26, 2016 4:11 PM EDT

Deckers Outdoor (NYSE: DECK) announced that Dave Powers will succeed Angel Martinez as Chief Executive Officer of Deckers Brands following Mr. Martinezs retirement, effective May 31,2016. Mr. Martinez will continue to serve as Chairman of the Companys board of directors.

The board of directors and management team has been working on this succession plan for some time as it was incredibly important for us to find the... More

Trading Radar for 5/26: Sears (SHLD), Signet (SIG), Deckers (DECK), GameStop (GME), Abercrombie & Fitch (ANF) Report

May 25, 2016 2:41 PM EDT

The Trading Radar highlights key earnings and economic announcements for the next trading session:

Before Markets Open:
Economics:
8:30am EDT

Initial Claims - Street sees 275kContinuing Claims - no Street consensusDurable Orders - Street sees 0.6%Durable Orders: ex-trans - Street sees 0.5%

Earnings:

Abercrombie & Fitch (NYSE: ANF) - consensus loss $0.51
Actions Semiconductor (Nasdaq: ACTS) - no Street... More

Deckers Outdoor (DECK) May weekly volatility elevated at 156 into Q4 and outlook

May 25, 2016 1:29 PM EDT

Deckers Outdoor (NASDAQ: DECK) May weekly call option implied volatility is at 156, June is at 60, July is at 45; compared to its 52-week range of 25 to 72 into the expected release of Q4 results on May 26.

... More